Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP464006.RAinq0t1aiC4ocaT7SY7Qi6hzllU0a8nXjOk2Ffvr_I6k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP464006.RAinq0t1aiC4ocaT7SY7Qi6hzllU0a8nXjOk2Ffvr_I6k130_assertion type Assertion NP464006.RAinq0t1aiC4ocaT7SY7Qi6hzllU0a8nXjOk2Ffvr_I6k130_head.
- NP464006.RAinq0t1aiC4ocaT7SY7Qi6hzllU0a8nXjOk2Ffvr_I6k130_assertion description "[RASSF2 was methylated in 88% of thyroid cancer cell lines and in 63% of primary thyroid carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP464006.RAinq0t1aiC4ocaT7SY7Qi6hzllU0a8nXjOk2Ffvr_I6k130_provenance.
- NP464006.RAinq0t1aiC4ocaT7SY7Qi6hzllU0a8nXjOk2Ffvr_I6k130_assertion evidence source_evidence_literature NP464006.RAinq0t1aiC4ocaT7SY7Qi6hzllU0a8nXjOk2Ffvr_I6k130_provenance.
- NP464006.RAinq0t1aiC4ocaT7SY7Qi6hzllU0a8nXjOk2Ffvr_I6k130_assertion SIO_000772 20920251 NP464006.RAinq0t1aiC4ocaT7SY7Qi6hzllU0a8nXjOk2Ffvr_I6k130_provenance.
- NP464006.RAinq0t1aiC4ocaT7SY7Qi6hzllU0a8nXjOk2Ffvr_I6k130_assertion wasDerivedFrom befree-20140225 NP464006.RAinq0t1aiC4ocaT7SY7Qi6hzllU0a8nXjOk2Ffvr_I6k130_provenance.
- NP464006.RAinq0t1aiC4ocaT7SY7Qi6hzllU0a8nXjOk2Ffvr_I6k130_assertion wasGeneratedBy ECO_0000203 NP464006.RAinq0t1aiC4ocaT7SY7Qi6hzllU0a8nXjOk2Ffvr_I6k130_provenance.